Chilton Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Chilton Capital Management's AMGN Position: Q1 2026 in Review
Chilton Capital Management reduced its Amgen (AMGN) stake by 32% in Q1 2026, selling an estimated $722K and leaving 4,306 shares worth $1.52M. The position accounts for 0.05% of the portfolio, ranked #109.
Chilton Capital Management first reported a position in AMGN in Q2 2022 and has held it in 16 quarters since. The position peaked at $23M in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Chilton Capital Management held 4,306 shares of Amgen worth $1.52M as of Q1 2026.
- Chilton Capital Management sold 2,026 Amgen shares in Q1 2026, an estimated $722K.
- Amgen made up 0.05% of Chilton Capital Management's portfolio in Q1 2026, its #109 holding.
- Chilton Capital Management first reported a position in Amgen in Q2 2022 and has held it in 16 quarters since.
- Chilton Capital Management's Amgen position peaked at $23M in Q3 2024.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Chilton Capital Management's 13F filing for Q1 2026, filed 11 May 2026.